Release Date: Apr 2019
CC: PC, MK, PBL, ICS, PR, SBP
George S. Cembrowski, MD, PhD
CEO, Laboratory Concision, CEO, Cembrowski & Cembrowski Quality Control Consulting, Edmonton, Alberta, Canada; Clinical Professor, Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada
After completing this course, participants will be able to:
Grasp the enormity of obesity-related disease.
Begin to understand the relationships between increased fat mass and changes in laboratory tests generally and in different ethnic populations.
Become crusaders for more efficient laboratory testing.
Who should attend? Practicing Pathologists, Residents, Doctoral Scientists, Pathologists’ Assistants, Laboratory Managers, Bench Supervisors, Bench Technologists & Technicians, Cytotechnologists, Histotechnologists, Phlebotomists
The food industry and lifestyle changes have caused obesity-related disease in hundreds of millions of people worldwide. In 2005, the U.S. healthcare costs of obesity-related illness were $190.2 billion -- 21% of medical spending! There is little understanding of the medical relevance of many of the charted “obesity” tests. This webcast will discuss the relationships of waist circumference to common chemistry and hematology tests and will present an approach for selecting and evaluating their utility in Mexican-American, non-Hispanic White and non-Hispanic Black males and females. A practical approach to limit the measurement of AST (aspartate aminotransferase) will also be discussed.